Form 4: Integra LifeSciences Executive Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
Robert T. Davis Jr., EVP & President, TT of Integra LifeSciences, disposed of 635 shares of common stock on March 10, 2024, to satisfy tax obligations.
Summary
- On March 10, 2024, Robert T. Davis Jr., an Executive Vice President and President, TT at Integra LifeSciences Holdings Corp, disposed of 635 shares of common stock.
- The transaction was executed to cover tax obligations arising from an unspecified event.
- The shares were disposed of at a price of $36.73 per share.
- Following the transaction, Davis directly owns 49,258 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for stock disposals by executives.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders, as it is a routine disposal of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/10/2024 | Date of stock disposal transaction |
| 03/12/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.